reports
Intra-Cellular Therapies Announces Proposed Public Offering of Common ...
Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock NEW YORK, April 16, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI) (“Intra-Cellular Therapies”), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that it has commenced an underwritten public offering of $500 million of shares of its common stock. In connection with the offering, Intra-Cellular Therapies intends to grant the underwriters a 30-day option to purchase up to an additional 15% ...
New York Mortgage Trust 2024 First Quarter Conference Call Scheduled f...
New York Mortgage Trust 2024 First Quarter Conference Call Scheduled for Thursday, May 2, 2024 NEW YORK, April 16, 2024 (GLOBE NEWSWIRE) -- New York Mortgage Trust, Inc. (Nasdaq: NYMT) (the “Company”) is scheduled to report financial results for the three months ended March 31, 2024 after the close of market on May 1, 2024. New York Mortgage Trust's executive management will host a conference call and audio webcast at 9:00 a.m., Eastern Time, on Thursday, May 2, 2024. To access the conference call, please pre-register using this . Registrants will receive confirmation with dial-in details...
Vespra Hills Golf Club Joins the ClubLink Family of Managed Clubs
Vespra Hills Golf Club Joins the ClubLink Family of Managed Clubs KING CITY, Ontario, April 16, 2024 (GLOBE NEWSWIRE) -- ClubLink Corporation ULC (subsidiary of TWC Enterprises Limited), Canada’s largest owner, operator and manager of Golf and Country Clubs, announced today that Vespra Hills Golf Club has joined the ClubLink family of managed Clubs. Established in 2003, nestled in the hills of Springwater Township, 10 minutes from downtown Barrie, Ontario and 45 minutes from the highway 407/400 interchange, the 27-hole Member Club will become a fully integrated, Gold-level Member Club ...
SuRo Capital Corp. First Quarter 2024 Preliminary Investment Portfolio...
SuRo Capital Corp. First Quarter 2024 Preliminary Investment Portfolio Update Net Asset Value Anticipated to be $6.90 to $7.40 Per Share NEW YORK, April 16, 2024 (GLOBE NEWSWIRE) -- (“SuRo Capital”, the “Company”, “we”, “us”, and “our”) (Nasdaq: ) today provided the following preliminary update on its investment portfolio for the first quarter ended March 31, 2024. “We remain incredibly enthusiastic about both our investment pipeline and our current portfolio as the IPO market strengthens and new opportunities at compelling valuations continue to come to light. We are now executing on...
Connect Biopharma Reports Full Year 2023 Financial Results and Provide...
Connect Biopharma Reports Full Year 2023 Financial Results and Provides Business Update Reported two positive readouts for rademikibart, the Company’s lead asset, from the Global Phase 2b trial in moderate-to-severe persistent asthma and from the China pivotal trial in moderate-to-severe atopic dermatitis (AD)Type C meeting in AD and End-of-Phase 2 (EoP2) meeting in asthma have been scheduled with the U.S. Food and Drug Administration (FDA) in Q2 2024 to discuss trial results and proposed registrational programsGranted Simcere the exclusive rights to develop, manufacture, and commercialize ...
ClearPoint Neuro Congratulates its Partner AviadoBio on First Patient ...
ClearPoint Neuro Congratulates its Partner AviadoBio on First Patient Treated in its ASPIRE-FTD Clinical Trial Evaluating AVB-101 for Frontotemporal Dementia with GRN Mutations ASPIRE-FTD Sites in the EU and U.S. to Use ClearPoint® Navigation Together With SmartFlow® Cannula for Intrathalamic Gene Therapy Administration SOLANA BEACH, Calif., April 16, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today congratulates its partner AviadoBio on treat...
Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4...
Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) DURHAM, N.C., April 16, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX) today announced that on April 10, 2024, the Compensation Committee of Chimerix’s Board of Directors granted inducement awards to four new employees of non-statutory stock options to purchase up to a total of 223,000 shares of Chimerix’s common stock. The Compensation Committee of Chimerix’s Board of Directors approved the awards as an inducement material to the new employees’ employment in accordance with Nasdaq Listing rule 5635(c)(4). The stock...
Open Lending to Announce First Quarter 2024 Results on May 7, 2024
Open Lending to Announce First Quarter 2024 Results on May 7, 2024 AUSTIN, Texas, April 16, 2024 (GLOBE NEWSWIRE) -- Corporation (NASDAQ: LPRO) (“Open Lending” or “the Company”), an industry trailblazer in automotive lending enablement and risk analytics solutions for financial institutions, today announced that the Company will host a conference call to discuss first quarter 2024 financial results on Tuesday, May 7, 2024 at 5:00pm ET. A press release with first quarter 2024 financial results will be issued after the market closes that same day. The conference call will be webcast live ...
Flywire to Announce First Quarter 2024 Results on May 7, 2024
Flywire to Announce First Quarter 2024 Results on May 7, 2024 BOSTON, April 16, 2024 (GLOBE NEWSWIRE) -- Today, (Flywire) (Nasdaq: FLYW), a global payments enablement and software company, announced that its first quarter 2024 financial results will be released after market close on Tuesday, May 7, 2024. Flywire will host a conference call to discuss its first quarter 2024 financial results at 5:00pm ET the same day. Hosting the call will be Mike Massaro, CEO, Rob Orgel, President and COO, Cosmin Pitigoi, CFO, and Akil Hollis, Head of Investor Relations. The conference call will be web...
IN8bio to Present at Noble Capital Markets Emerging Growth Virtual Hea...
IN8bio to Present at Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference NEW YORK, April 16, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: INAB) a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies, today announced that William Ho, CEO and Co-founder, will present at the Noble Capital Markets’ Emerging Growth Virtual Healthcare Equity Conference on Thursday, April 18th at 12:30pm ET. The formal presentation will feature a fireside style Q&A session with questions welcome from the live virtual audience. Attendees interested in viewing t...
Cricut to Announce First Quarter 2024 Financial Results on May 7, 2024
Cricut to Announce First Quarter 2024 Financial Results on May 7, 2024 SOUTH JORDAN, Utah, April 16, 2024 (GLOBE NEWSWIRE) -- Cricut, Inc. (“Cricut”) (NASDAQ: CRCT), the creative technology company that has brought a connected platform for making to millions of users worldwide, today announced it will report its financial results for the first quarter ended March 31, 2024 after the U.S. markets close on Tuesday, May 7, 2024. Cricut management will host a conference call and webcast to discuss the results that afternoon at 3:00 p.m. Mountain Time (5:00 p.m. Eastern Time). A live webcast o...
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listin...
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4) BRISBANE, Calif., April 16, 2024 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a clinical-stage biopharmaceutical company developing a new class of complement-based medicines for people living with devastating inflammatory-related diseases, today announced that it has granted inducement to two new non-executive employees under the terms of the 2022 Employment Inducement Award Plan. The equity awards were approved on April 12, 2024, in accordance with Nasdaq Listing Rule 5635(c)(4). In the aggregat...
A-Mark Precious Metals Sets Fiscal Third Quarter 2024 Earnings Call fo...
A-Mark Precious Metals Sets Fiscal Third Quarter 2024 Earnings Call for Tuesday, May 7, at 4:30 p.m. ET EL SEGUNDO, Calif., April 16, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: AMRK) (A-Mark), a leading fully integrated precious metals platform, will hold a conference call on Tuesday, May 7, 2024 at 4:30 p.m. Eastern time to discuss results for the fiscal third quarter ended March 31, 2024. Financial results will be issued in a press release prior to the call. A-Mark management will host the presentation, followed by a question-and-answer period. A-Mark’s conference call can be accessed as follo...
Madrigal Pharmaceuticals Reports Inducement Grants under Nasdaq Listin...
Madrigal Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) CONSHOHOCKEN, Pa., April 16, 2024 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company pursuing novel therapeutics for nonalcoholic steatohepatitis (NASH), today announced that the company granted equity awards to 7 new employees, in each case with a grant date of April 15, 2024, as equity inducement awards under the terms of the company's 2023 Inducement Plan. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4). The equity award...
Zapp EV Announces Reverse Stock Split
Zapp EV Announces Reverse Stock Split LONDON, April 16, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: ZAPP) (“Zapp EV” or the “Company”), owner of “Zapp”, the British electric vehicle brand on a mission to revolutionize personal urban mobility, today announced that its shareholders approved at the Company’s annual general meeting on April 11, 2024, and that the Company will effect, a consolidation of its authorized share capital at a ratio of 1-for-20 (the “Reverse Stock Split”), in order that the share capital of the Company be amended from US$50,000 divided into 500,000,000 ordinary shares of a no...
Kiniksa Pharmaceuticals to Report First Quarter 2024 Financial Results...
Kiniksa Pharmaceuticals to Report First Quarter 2024 Financial Results on April 23, 2024 HAMILTON, Bermuda, April 16, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: KNSA) announced today that it will host a conference call and live webcast on Tuesday, April 23, 2024 at 8:30 a.m. Eastern Time to report its first quarter 2024 financial results and recent portfolio execution. A live webcast will be accessible through the Investors & Media section of the company’s website at . Individuals interested in participating in the call via telephone may register . Upon registration, all telephone participants w...
Rhythm Pharmaceuticals Announces New Employment Inducement Grants
Rhythm Pharmaceuticals Announces New Employment Inducement Grants BOSTON, April 16, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives of patients and their families living with rare neuroendocrine diseases, today announced that on April 11, 2024, the Compensation Committee of Rhythm’s board of directors granted inducement equity grants covering an aggregate of 31,220 shares of its common stock to eight new employees, consisting of inducement stock options to purchase an aggregate of 16,480 s...
TScan Therapeutics Provides Clinical Pipeline Update and Highlights Ne...
TScan Therapeutics Provides Clinical Pipeline Update and Highlights Near-Term Priorities Over 40 solid tumor patients have completed all biomarker testing in the screening protocol; ~60% of these patients qualify for at least one TCR-T in the ImmunoBank and ~30% are eligible for multiplex therapy Patients identified across all six TCR-T cohorts in solid tumor program with dosing of first three expected in early May All eight patients in the heme program treated with TSC-100 or TSC-101 remain relapse-free with no detectable cancer to date; median follow-up of >10 months WALTHAM, Mass., Ap...
Evidence for Clene’s CNM-Au8® as a Treatment for Repair and Remyelinat...
Evidence for Clene’s CNM-Au8® as a Treatment for Repair and Remyelination in Multiple Sclerosis Presented in the Emerging Science Session at the 2024 American Academy of Neurology Annual Meeting Long term extension of the Phase 2 VISIONARY-MS clinical trial of CNM-Au8 demonstrated significant evidence of repair and remyelination across multiple paraclinical endpoints (change from original baseline, p
Freehold Royalties Ltd. Declares Dividend for April 2024
Freehold Royalties Ltd. Declares Dividend for April 2024 CALGARY, Alberta, April 16, 2024 (GLOBE NEWSWIRE) -- Freehold Royalties Ltd. (Freehold) (TSX: FRU) announces that its Board of Directors has declared a dividend of Cdn. $0.09 per common share to be paid on May 15, 2024 to shareholders of record on April 30, 2024. These dividends are designated as “eligible dividends” for Canadian income tax purposes. Freehold’s focus is on acquiring and managing oil and gas royalties. Freehold’s common shares trade on the Toronto Stock Exchange in Canada under the symbol FRU. For further informa...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.